May Measurement Month 2021: an analysis of blood pressure screening results from Mexico.

IF 1.7 4区医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

European Heart Journal Supplements Pub Date : 2024-07-24 eCollection Date: 2024-06-01 DOI:10.1093/eurheartjsupp/suae055

Luis Alcocer, Silvia Palomo, Ricardo A Rangel-Zertuche, María Guadalupe Berumen-Lechuga, Julio M Medina-Serrano, Luis Rey García-Cortés, Oliva Mejía-Rodríguez, Thomas Beaney, Gabriele Kerr, Neil R Poulter

{"title":"May Measurement Month 2021: an analysis of blood pressure screening results from Mexico.","authors":"Luis Alcocer, Silvia Palomo, Ricardo A Rangel-Zertuche, María Guadalupe Berumen-Lechuga, Julio M Medina-Serrano, Luis Rey García-Cortés, Oliva Mejía-Rodríguez, Thomas Beaney, Gabriele Kerr, Neil R Poulter","doi":"10.1093/eurheartjsupp/suae055","DOIUrl":null,"url":null,"abstract":"<p><p>May Measurement Month 2021 (MMM21) in Mexico was an opportunistic survey that aimed to improve blood pressure awareness at the individual and population levels and to analyse the impact of the COVID-19 pandemic on the prevalence, knowledge, and rates of hypertension in the country. This survey followed the methodology of MMM, previously published. The total number of participants screened was 77 547, of which 47 793 (61.6%) were female and 29 178 (37.6%) were male. The mean age (SD) was 46.2 (16.6) years. Of all 77 547 participants, 14 939 (19.3%) had hypertension, of which 48% were aware. The frequency and awareness of hypertension in this survey are similar to those reported before the pandemic (MMM19-Mexico and the 2019 National Health Survey), suggesting that the impact of the COVID-19 pandemic in these parameters of arterial hypertension was not as important as expected. These data are concordant with the official reports in Mexico that showed that the pandemic had a severe impact on cardiovascular mortality but did not modify mortality due to hypertension or stroke.</p>","PeriodicalId":11956,"journal":{"name":"European Heart Journal Supplements","volume":"26 Suppl 3","pages":"iii58-iii60"},"PeriodicalIF":1.7000,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11267704/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal Supplements","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartjsupp/suae055","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

May Measurement Month 2021 (MMM21) in Mexico was an opportunistic survey that aimed to improve blood pressure awareness at the individual and population levels and to analyse the impact of the COVID-19 pandemic on the prevalence, knowledge, and rates of hypertension in the country. This survey followed the methodology of MMM, previously published. The total number of participants screened was 77 547, of which 47 793 (61.6%) were female and 29 178 (37.6%) were male. The mean age (SD) was 46.2 (16.6) years. Of all 77 547 participants, 14 939 (19.3%) had hypertension, of which 48% were aware. The frequency and awareness of hypertension in this survey are similar to those reported before the pandemic (MMM19-Mexico and the 2019 National Health Survey), suggesting that the impact of the COVID-19 pandemic in these parameters of arterial hypertension was not as important as expected. These data are concordant with the official reports in Mexico that showed that the pandemic had a severe impact on cardiovascular mortality but did not modify mortality due to hypertension or stroke.

查看原文本刊更多论文

2021 年五月测量月：墨西哥血压筛查结果分析。

墨西哥 2021 年五月测量月（MMM21）是一项机会性调查，旨在提高个人和人群的血压意识，并分析 COVID-19 大流行对该国高血压患病率、知识和发病率的影响。此次调查采用了之前公布的 MMM 方法。接受筛查的总人数为 77 547 人，其中女性 47 793 人（占 61.6%），男性 29 178 人（占 37.6%）。平均年龄（标准差）为 46.2（16.6）岁。在所有 77 547 名参与者中，14 939 人（19.3%）患有高血压，其中 48% 意识到自己患有高血压。此次调查中的高血压发生率和知晓率与大流行前的报告（MMM19-墨西哥和 2019 年全国健康调查）相似，表明 COVID-19 大流行对动脉高血压这些参数的影响没有预期的那么重要。这些数据与墨西哥的官方报告一致，官方报告显示大流行对心血管死亡率产生了严重影响，但并未改变高血压或中风导致的死亡率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Heart Journal Supplements 医学-心血管系统

CiteScore

3.00

自引率

0.00%

发文量

575

审稿时长

12 months

期刊介绍： The European Heart Journal Supplements (EHJs) is a long standing member of the ESC Journal Family that serves as a publication medium for supplemental issues of the flagship European Heart Journal. Traditionally EHJs published a broad range of articles from symposia to special issues on specific topics of interest. The Editor-in-Chief, Professor Roberto Ferrari, together with his team of eminent Associate Editors: Professor Francisco Fernández-Avilés, Professors Jeroen Bax, Michael Böhm, Frank Ruschitzka, and Thomas Lüscher from the European Heart Journal, has implemented a change of focus for the journal. This entirely refreshed version of the European Heart Journal Supplements now bears the subtitle the Heart of the Matter to give recognition to the focus the journal now has. The EHJs – the Heart of the Matter intends to offer a dedicated, scientific space for the ESC, Institutions, National and Affiliate Societies, Associations, Working Groups and Councils to disseminate their important successes globally.